These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections. Johansson BE, Kilbourne ED. J Infect Dis; 1990 Oct; 162(4):800-9. PubMed ID: 2401790 [Abstract] [Full Text] [Related]
5. Cross-protection in mice after immunization with H2N2, H3N2, and Heq2Neq2 influenza virus strains. Anker WJ, Bakker AK, Masurel N. Infect Immun; 1978 Jul; 21(1):96-101. PubMed ID: 711325 [Abstract] [Full Text] [Related]
7. Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West). Werner J, Schudrowitz C, Köhler H. Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):440-6. PubMed ID: 56831 [Abstract] [Full Text] [Related]
14. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA. J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855 [Abstract] [Full Text] [Related]
15. Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition. Johansson BE, Pokorny BA, Tiso VA. Vaccine; 2002 Feb 22; 20(11-12):1670-4. PubMed ID: 11858877 [Abstract] [Full Text] [Related]
16. Evaluation of recombinant A/Victoria/3/75 (H3N2) influenza neuraminidase mutants as potential broad-spectrum subunit vaccines against influenza A. Martinet W, Deroo T, Saelens X, Beirnaert E, Vanlandschoot P, Contreras R, Fiers W, Min Jou W. Arch Virol; 1998 Feb 22; 143(10):2011-9. PubMed ID: 9856088 [Abstract] [Full Text] [Related]
17. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans. Kilbourne ED. J Infect Dis; 1976 Oct 22; 134(4):384-94. PubMed ID: 789791 [Abstract] [Full Text] [Related]
19. Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type. Sandbulte MR, Gauger PC, Kitikoon P, Chen H, Perez DR, Roth JA, Vincent AL. Vaccine; 2016 Jul 19; 34(33):3773-9. PubMed ID: 27325350 [Abstract] [Full Text] [Related]
20. The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis. Naikhin AN, Tsaritsina IM, Oleinikova EV, Syrodoeva LG, Korchanova NL, Denisov GM, Shvartsman YaS. J Hyg (Lond); 1983 Aug 19; 91(1):131-8. PubMed ID: 6886409 [Abstract] [Full Text] [Related] Page: [Next] [New Search]